ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Charles River Laboratories has entered into a definitive agreement to acquire Ashland, Ohio-based WIL Research for $585 million in cash. WIL had sales last year of $215 million and provides safety assessment and contract development and manufacturing services to pharmaceutical, agricultural, and chemical firms. Charles River says the acquisition will enhance its position as an early-stage contract research organization, allow it to increase services to biotechnology clients, and expand its footprint in Europe, where WIL has operations in the Netherlands and France.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter